We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitiv... MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland. Show more
International Business Machines (NYSE:IBM) – According to the South China Morning Post, IBM has closed its R&D operations in China, laying off over 1,000 employees due to geopolitical...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.2317 | -17.1413775246 | 1.3517 | 1.43 | 1.1 | 542195 | 1.23178839 | CS |
4 | -0.81 | -41.9689119171 | 1.93 | 2.7 | 1.1 | 2482003 | 1.92256399 | CS |
12 | 0.46 | 69.696969697 | 0.66 | 5.01 | 0.51 | 5929916 | 3.39628573 | CS |
26 | -0.03 | -2.60869565217 | 1.15 | 5.01 | 0.51 | 2772603 | 3.33820323 | CS |
52 | -3.06 | -73.2057416268 | 4.18 | 6.4 | 0.51 | 1621043 | 3.13299407 | CS |
156 | -5.88 | -84 | 7 | 7.9799 | 0.51 | 1451787 | 3.16014258 | CS |
260 | -5.88 | -84 | 7 | 7.9799 | 0.51 | 1451787 | 3.16014258 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions